{"id":22319,"date":"2024-01-12T07:53:39","date_gmt":"2024-01-12T12:53:39","guid":{"rendered":"https:\/\/medicarereport.org\/?p=22319"},"modified":"2024-01-12T07:53:40","modified_gmt":"2024-01-12T12:53:40","slug":"new-gene-therapy-treatment-to-fight-bladder-cancer","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=22319","title":{"rendered":"New gene therapy treatment to fight bladder cancer"},"content":{"rendered":"\n<p>(Source &#8211; news.va.gov)<\/p>\n\n\n\n<p>An Army Veteran from Houston received a dose of optimism when he came in for a groundbreaking new gene therapy treatment at Michael E. DeBakey VA. Sammie Robertson is the first VA patient in the country to receive a dose of Adstiladrin, the first and only FDA-approved gene therapy to help fight non-muscle-invasive bladder cancer.  Continue reading <a href=\"https:\/\/news.va.gov\/127496\/new-gene-therapy-treatment-fight-bladder-cancer\/\" data-type=\"link\" data-id=\"https:\/\/news.va.gov\/127496\/new-gene-therapy-treatment-fight-bladder-cancer\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"250\" height=\"60\" class=\"wp-image-20064\" style=\"width: 250px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2022\/08\/VA-dept-of-vet-affairs.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2022\/08\/VA-dept-of-vet-affairs.png 418w, https:\/\/medicarereport.org\/wp-content\/uploads\/2022\/08\/VA-dept-of-vet-affairs-300x72.png 300w\" sizes=\"auto, (max-width: 250px) 100vw, 250px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice:<\/strong>&nbsp;The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Source &#8211; news.va.gov) An Army Veteran from Houston received a dose of optimism when he came in for a groundbreaking<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31,12,7],"tags":[1091,402,76,87,245],"class_list":["post-22319","post","type-post","status-publish","format-standard","hentry","category-fda","category-health-care-general","category-veterans-benefits","tag-adstiladrin","tag-cancer","tag-fda","tag-veterans","tag-veterans-health-care"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22319","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22319"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22319\/revisions"}],"predecessor-version":[{"id":22320,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/22319\/revisions\/22320"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22319"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22319"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22319"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}